Seven novel modulators of the analgesic target <scp>Na<sub>V</sub></scp>1.7 uncovered using a high‐throughput venom‐based discovery approach
Julie K. Klint(Evotec (Germany)), Glenn F. King(The University of Queensland), Richard J. Lewis(AstraZeneca (Netherlands)), Frank Bosmans(Vrije Universiteit Brussel), Mehdi Mobli(The University of Queensland), Volker Herzig(University of Tübingen), Sebastian Senff(The University of Queensland), Darshani B. Rupasinghe(The University of Queensland), Irina Vetter(Centre National de la Recherche Scientifique), Sing Yan Er(The University of Queensland), Jennifer J. Smith(The University of Queensland)
Cited by 82
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422